Cystatin C: A Candidate Biomarker for Amyotrophic Lateral Sclerosis

Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics

(2010) Henrik Ryberg et al.   MUSCLE & NERVE

Prognostic factors in ALS: A critical review

(2009) Adriano Chiò et al.   Amyotrophic Lateral Sclerosis

Association of cystatin C with adverse outcomes

(2009) Magdalena Madero et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

The need for biomarkers in amyotrophic lateral sclerosis drug development

(2009) K. R. Wagner   NEUROLOGY

Cystatin C in cerebrospinal fluid as a biomarker of ALS

(2009) Sachiko Tsuji-Akimoto et al.   NEUROSCIENCE LETTERS

Cystatin C: current position and future prospects

(2008) Sophie Séronie-Vivien et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Protein biomarkers for amyotrophic lateral sclerosis

(2008) Henrik Ryberg et al.   Expert Review of Proteomics

Biomarkers in amyotrophic lateral sclerosis

(2008) Martin R Turner et al.   LANCET NEUROLOGY

A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis

(2008) R. M. Mitchell et al.   NEUROLOGY

Bunina bodies in amyotrophic lateral sclerosis

(2008) Koichi Okamoto et al.   NEUROPATHOLOGY

Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues

(2007) G Logroscino et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY